Your browser doesn't support javascript.
loading
miR-203a suppresses cell proliferation by targeting RING-finger protein 6 in colorectal cancer.
Miao, Jiyu; Hou, Ni; Yang, Wanwan; Jiang, Qiuyu; Xue, Wanjuan; Wang, Xiaofei; Zhang, Huahua; Xiong, Xiaofan; Wang, Lumin; Zhao, Lingyu; Huang, Chen.
Afiliação
  • Miao J; Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center.
  • Hou N; Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center.
  • Yang W; Department of anesthesiology and Perioperative Medicine, Xijing Hospital, the Fourth Military Medical University, Xi'an.
  • Jiang Q; Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center.
  • Xue W; Medical College, Yan'an University, Yan'an.
  • Wang X; Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University Health Science Center, Xi'an, China.
  • Zhang H; Medical College, Yan'an University, Yan'an.
  • Xiong X; Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center.
  • Wang L; Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center.
  • Zhao L; Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center.
  • Huang C; Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center.
Anticancer Drugs ; 31(6): 583-591, 2020 07.
Article em En | MEDLINE | ID: mdl-32282367
ABSTRACT
Colorectal cancer (CRC) is one of most common cancers worldwide. Although miR-203a is reported as a tumor suppressor involved in cell progression in some cancers, the role of miR-203a in CRC is still controversial and the underling mechanism of miR-203a in CRC remains unclear. Here, we demonstrated that low expression of miR-203a had poorer survival in CRC patients. miR-203a was down-regulated in most human colon cancer cells. Overexpression of miR-203a could inhibit colon cancer cell proliferation and arrest cell cycle in G1 phase. Bioinformatics and dual luciferase reporter assay confirmed that RING-finger protein 6 (RNF6) was a target gene of miR-203a. Silencing RNF6 inhibited cell proliferation and arrest cell cycle in G1 phase. RNF6 overexpression reversed the effects of miR-203a overexpression in colon cancer cells. Taken together, our data indicate that miR-203a inhibits colon cancer cell proliferation by targeting RNF6, offer novel insights into the regulatory network of miR-203a-modulated cell cycle and proliferation, and suggest that miR-203a a potential therapeutic target in CRC treatment.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / MicroRNAs / Proliferação de Células / Proteínas de Ligação a DNA Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Anticancer Drugs Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / MicroRNAs / Proliferação de Células / Proteínas de Ligação a DNA Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Anticancer Drugs Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2020 Tipo de documento: Article